Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$5.28 - $9.64 $220,704 - $402,952
-41,800 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$5.75 - $7.13 $4,370 - $5,418
-760 Reduced 1.79%
41,800 $273,000
Q3 2020

Nov 09, 2020

SELL
$4.9 - $7.12 $61,740 - $89,712
-12,600 Reduced 22.84%
42,560 $260,000
Q2 2020

Aug 13, 2020

BUY
$6.43 - $9.86 $354,678 - $543,877
55,160 New
55,160 $400,000
Q3 2017

Nov 14, 2017

SELL
$15.1 - $19.25 $201,207 - $256,506
-13,325 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
13,325
13,325 $272,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.